Marshall Wace
CLVS

Marshall Wace’s Clovis Oncology, Inc. CLVS Stock Holding History

Marshall Wace’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-310,123
Closed -$370K – 3728
2022
Q3 		$370K Buy
310,123
+223,880
+260% +$349K ﹤0.01% 2864
2022
Q2 		$155K Buy
+86,243
New +$127K ﹤0.01% 3217
2019
Q4 		– Sell
-63,476
Closed -$249K – 2188
2019
Q3 		$249K Buy
+63,476
New +$513K ﹤0.01% 1244
2019
Q1 		– Sell
-36,184
Closed -$650K – 2148
2018
Q4 		$650K Buy
36,184
+21,787
+151% +$445K 0.01% 1026
2018
Q3 		$423K Buy
+14,397
New +$557K ﹤0.01% 957
2017
Q4 		– Sell
-18,567
Closed -$1.52M – 497
2017
Q3 		$1.52M Buy
18,567
+12,426
+202% +$985K 0.07% 187
2017
Q2 		$577K Buy
+6,141
New +$376K 0.03% 226
2017
Q1 		– Sell
-83,014
Closed -$3.69M – 831
2016
Q4 		$3.69M Sell
83,014
-82,723
-50% -$2.91M 0.02% 538
2016
Q3 		$5.97M Buy
+165,737
New +$3.56M 0.04% 377
2015
Q4 		– Sell
-8,208
Closed -$755K – 1169
2015
Q3 		$755K Buy
+8,208
New +$710K 0.01% 670
2014
Q4 		– Sell
-4,642
Closed -$211K – 1024
2014
Q3 		$211K Buy
+4,642
New +$194K ﹤0.01% 772

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Marshall Wace's CLVS Position: Q4 2022 in Review

Marshall Wace sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 310,123 shares — an estimated $370K sold.

Marshall Wace first reported a position in CLVS in Q3 2014 and held it in 11 quarters. The position peaked at $5.97M in Q3 2016. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Marshall Wace reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 310,123 Clovis Oncology, Inc. shares in Q4 2022, an estimated $370K.
  • Marshall Wace first reported a position in Clovis Oncology, Inc. in Q3 2014 and held it in 11 quarters.
  • Marshall Wace's Clovis Oncology, Inc. position peaked at $5.97M in Q3 2016.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.